{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:28:53Z","timestamp":1791919733242,"version":"4.3.4"},"reference-count":24,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:sec>\n<jats:title>OBJECT<\/jats:title>\n<jats:p>This study explored whether there were differences between the autoimmune disease prevalence rates in unilateral and bilateral moyamoya disease (MMD).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>The authors performed a retrospective review of data obtained from the medical records of their hospital, analyzing and comparing the clinical characteristics and prevalence rates of all autoimmune diseases that were associated with unilateral and bilateral MMD in their hospital from January 1995 to October 2014.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Three hundred sixteen patients with bilateral MMD and 68 with unilateral MMD were identified. The results indicated that patients with unilateral MMD were more likely to be female than were patients with bilateral MMD (67.6% vs 51.3%, p = 0.014, odds ratio [OR] 1.99). Overall, non-autoimmune comorbidities tended to be more prevalent in the unilateral MMD cases than in the bilateral MMD cases (17.6% vs 9.8%, p = 0.063, OR 1.97, chi-square test). Autoimmune thyroid disease and other autoimmune diseases also tended to be more prevalent in the unilateral MMD cases than in the bilateral MMD cases (19.1% vs 10.8%, p = 0.056, OR 1.96 and 8.8% vs 3.5%, p = 0.092, OR 2.77, respectively, chi-square test). The overall autoimmune disease prevalence in the unilateral MMD cases was significantly higher than in the bilateral MMD cases (26.5% vs 13.6%, p = 0.008, OR 2.29, 95% CI 1.22\u20134.28, chi-square test). Multiple logistic regression analysis showed that autoimmune disease was more likely to be associated with unilateral than with bilateral MMD (p = 0.039, OR 10.91, 95% CI 1.13\u2013105.25).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>This study indicated a higher overall autoimmune disease prevalence in unilateral than in bilateral MMD. Unilateral MMD may be more associated with autoimmune disease than bilateral MMD. Different pathogenetic mechanisms may underlie moyamoya vessel formation in unilateral and bilateral MMD.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2015.4.jns142936","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T13:59:26Z","timestamp":1443189566000},"page":"1215-1220","source":"Crossref","is-referenced-by-count":33,"title":["Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease"],"prefix":"10.3171","volume":"124","author":[{"given":"Jian-Bin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Xue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns142936","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/STROKEAHA.113.004273","article-title":"Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study","volume":"45","author":"Ahn","year":"2014"},{"key":"b2-jns142936","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/STROKEAHA.111.000307","article-title":"Moyamoya disease in a primarily white, Midwestern US population: increased prevalence of autoimmune disease","volume":"44","author":"Bower","year":"2013"},{"key":"b3-jns142936","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/STROKEAHA.111.621300","article-title":"Moyamoya disease in China: its clinical features and outcomes","volume":"43","author":"Duan","year":"2012"},{"issue":"Suppl 2","key":"b4-jns142936","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1016\/S0303-8467(97)00082-6","article-title":"Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (\u2018moyamoya\u2019 disease) Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan","volume":"99","author":"Fukui","year":"1997"},{"key":"b5-jns142936","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2014.06.010","article-title":"A nationwide survey on unilateral moyamoya disease in Japan","volume":"124","author":"Hayashi","year":"2014"},{"key":"b6-jns142936","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.clineuro.2012.09.020","article-title":"An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan","volume":"115","author":"Hayashi","year":"2013"},{"key":"b7-jns142936","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3171\/jns.1996.85.5.0772","article-title":"Is \u201cunilateral\u201d moyamoya disease different from moyamoya disease?","volume":"85","author":"Houkin","year":"1996"},{"key":"b8-jns142936","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3171\/2013.1.JNS12565","article-title":"Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings","volume":"118","author":"Jiang","year":"2013"},{"key":"b9-jns142936","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1227\/NEU.0b013e31827b9beb","article-title":"Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease","volume":"72","author":"Kainth","year":"2013"},{"key":"b10-jns142936","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3171\/2014.1.JNS13946","article-title":"The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review","volume":"121","author":"Kazumata","year":"2014"},{"key":"b11-jns142936","series-title":"Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000093238","article-title":"Progression of unilateral moyamoya disease: A clinical series","volume":"22","author":"Kelly","year":"2006"},{"key":"b12-jns142936","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1212\/WNL.0b013e3182825162","article-title":"High-resolution MR technique can distinguish moyamoya disease from atherosclerotic occlusion","volume":"80","author":"Kim","year":"2013"},{"key":"b13-jns142936","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/STROKEAHA.109.562264","article-title":"Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study","volume":"41","author":"Kim","year":"2010"},{"key":"b14-jns142936","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda","year":"2008"},{"key":"b15-jns142936","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/01.STR.29.4.868","article-title":"Autoimmunity in Down\u2019s syndrome: another possible mechanism of moyamoya disease","volume":"29","author":"Leno","year":"1998"},{"key":"b16-jns142936","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/STROKEAHA.110.608471","article-title":"Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease: a case-control study","volume":"42","author":"Li","year":"2011"},{"key":"b17-jns142936","series-title":"Intern Med","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2169\/internalmedicine.45.1543","article-title":"Co-morbidity of moyamoya disease with Graves\u2019 disease Report of three cases and a review of the literature","volume":"45","author":"Sasaki","year":"2006"},{"key":"b18-jns142936","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009"},{"key":"b19-jns142936","series-title":"Clin Neurol Neurosurg","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.clineuro.2010.11.022","article-title":"Moyamoya disease complicated by Graves\u2019 disease and type 2 diabetes mellitus: report of two cases","volume":"113","author":"Suzuki","year":"2011"},{"key":"b20-jns142936","series-title":"Thyroid","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/thy.1997.7.625","article-title":"Concurrence of Graves\u2019 disease and dysplastic cerebral blood vessels of the moyamoya variety","volume":"7","author":"Tendler","year":"1997"},{"key":"b21-jns142936","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1212\/01.wnl.0000176066.33797.82","article-title":"Moyamoya disease in Washington State and California","volume":"65","author":"Uchino","year":"2005"},{"key":"b22-jns142936","series-title":"AJNR Am J Neuroradiol","first-page":"1541","article-title":"Reversible MR angiographic findings in a patient with autoimmune Graves disease","volume":"25","author":"Utku","year":"2004"},{"key":"b23-jns142936","series-title":"Lupus","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0961203313485828","article-title":"Systemic lupus erythematosus associated with moyamoya syndrome: a case report and literature review","volume":"22","author":"Wang","year":"2013"},{"key":"b24-jns142936","series-title":"Diabetes Res Clin Pract","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.diabres.2004.04.005","article-title":"Chorea and Broca aphasia induced by diabetic ketoacidosis in a type 1 diabetic patient diagnosed as moyamoya disease","volume":"67","author":"Watanabe","year":"2005"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/124\/5\/article-p1215.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/124\/5\/article-p1215.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/124\/5\/article-p1215.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:55:50Z","timestamp":1709978150000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/124\/5\/article-p1215.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":24,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2015.4.jns142936","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}